Acumen Pharmaceuticals Inc (ABOS) financials · $73.3M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Acumen Pharmaceuticals Inc (ABOS) $73.3M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$123.8M | -$114.0M |
| Net Income | -$121.3M | -$102.3M |
| EPS (Diluted) | -$2.00 | -$1.71 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $122.8M | $239.0M |
| Current Assets | $122.3M | $178.3M |
| Cash & Equivalents | $54.0M | $35.6M |
| PP&E | $103.0K | $73.0K |
| Total Liabilities | $52.4M | $57.2M |
| Current Liabilities | $30.0M | $27.6M |
| Short-term Debt | $8.77M | N/A |
| Long-term Debt | $22.4M | $29.4M |
| Total Debt | $31.2M† | $29.4M† |
| Shareholders' Equity | $70.4M | $181.8M |
| Retained Earnings | -$446.5M | -$325.1M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$115.5M | -$86.2M |
| CapEx | $88.0K | $16.0K |
| Investing Cash Flow | $133.9M | $48.0M |
| Financing Cash Flow | -$34.0K | $6.93M |
| Free Cash Flow | -$115.6M | -$86.2M |
FAQ
What is ABOS P/E and revenue?
Acumen Pharmaceuticals Inc (ABOS) $73.3M cap.
What is ABOS revenue?
ABOS income-statement cache has no revenue figure yet.
Is ABOS profitable?
Acumen Pharmaceuticals Inc last cached net income is -$121.3M (FY2025).
What are ABOS total assets?
Acumen Pharmaceuticals Inc last cached total assets are $122.8M (FY2025).
What is ABOS free cash flow?
Acumen Pharmaceuticals Inc last cached free cash flow is -$115.6M (FY2025).
Not investment advice. Cached statements, not a live tape.